NextCure (NXTC) Earnings Date, Estimates & Call Transcripts → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free NXTC Stock Alerts $1.59 +0.01 (+0.63%) (As of 02:22 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateAug. 1EstimatedActual EPS (Mar. 21) -$0.52 Beat By $0.02 Consensus EPS (Mar. 21) -$0.54 Get NextCure Earnings AlertsEnter your email address below to receive the latest news and earnings results for NXTC and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueNXTC Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.NXTC Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Priority GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide NextCure Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($1.65) EPSNext Year EPS Consensus Estimate: ($1.62) EPSNXTC Earnings Date and InformationNextCure last announced its earnings results on March 21st, 2024. The reported ($0.52) EPS for the quarter, topping the consensus estimate of ($0.54) by $0.02. NextCure has generated ($2.28) earnings per share over the last year (($2.28) diluted earnings per share). Earnings for NextCure are expected to grow in the coming year, from ($1.65) to ($1.62) per share. NextCure has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off prior year's report dates.Read More NextCure Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/1/2024Estimated)------- 3/21/2024Q4 2023($0.54)($0.52)+$0.02($0.52)--11/2/2023Q3 2023($0.64)($0.51)+$0.13($0.51)--8/3/2023Q2 2023($0.60)($0.64)($0.04)($0.64)--5/4/2023Q1 2023($0.64)($0.58)+$0.06($0.58)--3/2/2023Q4 2022($0.65)($0.62)+$0.03($0.62)--11/3/2022Q3 2022($0.60)($0.68)($0.08)($0.68)-- Get the Latest News and Ratings for NXTC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NextCure and its competitors with MarketBeat's FREE daily newsletter. 8/4/2022Q2 2022($0.73)($0.65)+$0.08($0.65)--5/5/2022Q1 2022($0.68)($0.74)($0.06)($0.74)--3/3/2022Q4 2021($0.67)($0.61)+$0.06($0.61)--11/4/2021Q3 2021($0.67)($0.65)+$0.02($0.65)--8/5/2021Q2 2021($0.61)($0.65)($0.04)($0.65)-- NextCure Earnings - Frequently Asked Questions When is NextCure's earnings date? NextCure has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off last year's report dates. Learn more on NXTC's earnings history. Did NextCure beat their earnings estimates last quarter? In the previous quarter, NextCure (NASDAQ:NXTC) reported ($0.52) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.54) by $0.02. Learn more on analysts' earnings estimate vs. NXTC's actual earnings. How much profit does NextCure generate each year? NextCure (NASDAQ:NXTC) has a recorded net income of -$62.72 million. NXTC has generated -$2.28 earnings per share over the last four quarters. What is NextCure's EPS forecast for next year? NextCure's earnings are expected to grow from ($1.65) per share to ($1.62) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Lexaria Bioscience Earnings Unicycive Therapeutics Earnings Cara Therapeutics Earnings Sensei Biotherapeutics Earnings Nabriva Therapeutics Earnings Immuneering Earnings Xilio Therapeutics Earnings Eyenovia Earnings Bolt Biotherapeutics Earnings VYNE Therapeutics Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:NXTC) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorFidelity, Bezos, Goldman Bet Big on Tiny BiotechBehind the MarketsAI “wealth window” is closing June 25thParadigm PressElon Musk Secret Crypto Plot ExposedCrypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeShocking: One AI startup's revenue could surge 4,735%Manward PressThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NextCure, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.